RecruitingNot Applicable

Non Interventional German Leptomeningeal Disease Register

Germany50 participantsStarted 2024-06-26

Plain-language summary

The planned multicenter register is intended to create a database in the form of a cancer register on the incidence and course of disease in Germany of leptomeningeal disease, the therapeutic measures administered in the real world and the complications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with leptomeningeal disease * Written consent of the patient or legal guardian. * Capacity to give consent or legal guardianship * Age ≥ 18 years Exclusion Criteria: * Lack of informed consent from the patient * Lack of capacity to consent on the part of the person concerned or lack of legal guardianship * Age \< 18 years

What they're measuring

Progression-free survival depending on the treatment modalities

Timeframe: through study completion, an average of 1 year

Overall survival depending on the treatment modalities

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT06146010

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-01

Contact for this trial

Ghazaleh Tabatabai, Prof

+497071-29 Tabatabai.Office@med.uni-tuebingen.de

View on ClinicalTrials.gov More Meningeal Neoplasms trials